Entry |
|
Name |
Fosfomycin (USAN/INN); Phosphonomycin |
Formula |
C3H7O4P
|
Exact mass |
138.0082
|
Mol weight |
138.06
|
Structure |
|
Simcomp |
|
Source |
Streptomyces [TAX: 1883], Streptomyces fradiae [TAX: 1906]
|
Remark |
Product (DG00633): | D00925<US> D02187<JP> D02188<JP> |
|
Efficacy |
Antibacterial, Cell wall biosynthesis inhibitor |
Target |
UDP-N-acetylglucosamine 1-carboxyvinyltransferase [KO: K00790] |
Pathway |
|
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01X OTHER ANTIBACTERIALS
J01XX Other antibacterials
J01XX01 Fosfomycin
D04253 Fosfomycin (USAN/INN)
S SENSORY ORGANS
S02 OTOLOGICALS
S02A ANTIINFECTIVES
S02AA Antiinfectives
S02AA17 Fosfomycin
D04253 Fosfomycin (USAN/INN)
Antimicrobials [BR:br08307]
Antibacterials
Cell wall biosynthesis inhibitor, other
Other peptidoglycan biosynthesis inhibitor
D04253 Fosfomycin (USAN/INN)
Antimicrobials abbreviations [BR:br08327]
Antibacterials
Cell wall biosynthesis inhibitor, other
Other peptidoglycan biosynthesis inhibitor
DG00633 Fosfomycin
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 8
1 C1y C 18.4271 -7.9889
2 C1y C 19.8321 -7.9889
3 O2x O 19.1260 -6.7808
4 P1b P 17.2055 -8.6936
5 C1a C 21.0259 -8.6740
6 O1c O 15.9931 -9.3936
7 O1c O 16.5035 -7.4773
8 O1c O 17.9030 -9.9021
BOND 8
1 1 2 1
2 2 3 1
3 3 1 1
4 1 4 1 #Up
5 2 5 1 #Up
6 4 6 2
7 4 7 1
8 4 8 1
|